IRCT20230814059145N1招募中3 期
Aripiprazole as an adjuvant treatment for obsessive and compulsive symptoms in bipolar disorder: A randomized, double-blind, placebo-controlled clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Age 18 to 60 years
- •Confirmation of bipolar disorder based on DSM-5 criteria
排除标准
- •Not having cardiovascular, respiratory, kidney or digestive diseases
- •Not pregnant
- •Not suffering from drug or alcohol abuse
研究者
相似试验
已完成
3 期
The effect of Aripiprazole on obsessive compulsive symptomsSchizophreniaIRCT20181001041192N1Mazandaran University of Medical Sciences40
尚未招募
Unknown
Aripiprazole augmentation for obsessive-compulsive symptoms of major depressive disorderKCT0009595Chung-Ang Univerisity Hospital60
进行中（未招募）
不适用
A pilot study of Aripiprazole treatment for antipsychotic induced hyperprolactinaemia in young patients with severe mental illness and learning disabilities. - Aripiprazole and Prolactin Study- Version 1Antipsychotic induced hyperprolactinaemiaMedDRA version: 12Level: LLTClassification code 10020737Term: HyperprolactinaemiaEUCTR2009-011228-73-GBniversity of Oxford
已完成
不适用
Adjunctive treatment with Aripiprazole for Risperidone –induced hyperprolactinemiahyperprolactinemia induced by risperidone.HyperprolactinaemiaIRCT201307182181N6tabriz university of medical science40
已完成
不适用
Augmentation therapy with aripiprazole in selective serotonin reuptake inhibitor(SSRI)-refractory obsessive-compulsive disorder(OCD); A randomized double blind placebo controlled trialobsessive-compulsive disorderJPRN-UMIN000008743Kyushu University60